Global Anti-Fibrinolytic Drugs Market to Grow at a CAGR of 5% During 2024-2032, Aided by the Increasing Investments in R&D and Health Care

North America was a leading market for anti-fibrinolytic drugs in the historical period and is expected to continue the trend over the forecast period. This dominance of the region can be correlated to the rising adoption of the drug in gynaecology. Based on types, lysteda (a tranexamic acid derivative) is one of the most common anti-fibrinolytic drug used for menorrhagia.

Anti-fibrinolytic drugs are used for the treatment of trauma, which is reported to be the major cause of death across the globe. Haemophilia A and B, platelet dysfunctions, and various other bleeding disorders also require anti-fibrinolytic drugs to inhibit fibrinolysis. The rising health awareness regarding these ailments is expected to aid the anti-fibrinolytic drugs industry growth in the coming years.

Pfizer Inc. (NYSE: PFE) is one of the prominent players in the anti-fibrinolytic drug industry. The company manufactures Cyklokapron, which is one of the widely used anti-fibrinolytic drugs across the industry. Alongside Pfizer Inc., other key market players, like Sanofi SA (NASDAQ: SNY), have invested in anti-fibrinolytic drug research, which is expected to aid the market growth in the forecast period. Rising investments, along with the increasing road accidents, are also predicted to provide a significant boost to the market growth in the coming years.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Form, Type, Indication, End Use, and Region:

• Based on form, the market is broadly classified into oral and injectables.

• The market on the basis of type can be divided into amicor, aminocaproic acid, aprotinin, lysteda, RiaSTAP, fibrinogen, tranexamic acid, and trasylol, among others.

• On the basis of indication, the market is segmented into gynaecology, hereditary angioedema, fibrinolytic response testing, and surgeries, among others.

• Based on end-use, the market is categorised into hospitals, ambulatory surgery centres, health care specialty processes, and clinics, among others.

• The regional markets for anti-fibrinolytic drugs include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The anti-fibrinolytic drug industry is being driven by its growing adoption in the treatment of menorrhagia.

• A rapid increase in the frequency of road accidents and medical surgeries is also accelerating the industry growth.

• The market is expected to receive a further boost from the growing R&D activities and increased health care investments in the developing nations.

• The usage of the drugs in the treatments of haemophilia and other bleeding disorders is further aiding the growth of the overall market.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for anti-fibrinolytic drugs for the periods (2018-2023) and (2024-2032).

• The report also offers the historical (2018-2023) and forecast (2024-2032) markets for the forms, types, indications, end-uses, and major regions of anti-fibrinolytic drugs.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global anti-fibrinolytic drugs market are Pfizer Inc., Sanofi SA, Akorn, Inc, Cadila Healthcare Ltd., and Takeda Pharmaceutical Company Limited, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790